With midterm elections approaching, uncertainty is building around the next phase of the congressional calendar. In this View from Washington D.C., Jeffrey Ekoma, VP of Government Affairs, talks about the latest developments in Washington and what they could mean for health policy and federal funding. He discusses the status of key Health and Human Services nominations, including leadership positions at HHS, ASPR, FDA, the Surgeon General’s office, and SAMHSA. Jeffrey also breaks down the competing scenarios for FY2027 appropriations, including the possibility of a short-term extension, full-year appropriations, or a full-year continuing resolution.
1222: View from Washington D.C.: Nominations, FY2027 Funding & the Post-Midterm Outlook
Sign Up for Public Health Weekly Newsletter
Email has been submitted.
Recent Episodes
- 1222: View from Washington D.C.: Nominations, FY2027 Funding & the Post-Midterm Outlook
- 1221: How Real-World Data Can Strengthen Public Health
- 1220: Prioritizing Infectious Disease Investigations
- 1219: Using Data to Drive Better Maternal Health Outcomes
- 1218: Strengthening Nutrition for Infants and Toddlers
- 1217: Building Stronger Public Health Advocacy on Capitol Hill
- 1216: Leading Public Health Through Change
- 1215: Telling the Story of Public Health Preparedness
- 1214: What Public Health Needs to Know About New World Screwworm
- See all →
Spotify
Apple Podcasts
Amazon Music